# IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion

> **NCT00624000** · NA · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 7 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** IV tpa (Alteplase) vs IA tpa (Alteplase)

## Key facts

- **NCT ID:** NCT00624000
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2007-09
- **Final completion:** 2008-12
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2011-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00624000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00624000, "IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00624000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*